Background: Fetal blood pressure increases during late gestation; however, the underlying vascular mechanisms are unclear. Knowledge of the maturation of resistance arteries is important to identify the mechanisms and vulnerable periods for the development of vascular dysfunction in adulthood. Methods: We determined the functional and structural development of fetal sheep mesenteric resistance arteries using wire myography and immunohistochemistry. Results: Media mass and distribution of myosin heavy-chain isoforms showed no changes between 0.7 (100 ± 3 days) and 0.9 (130 ± 3 days) gestation. However, from 0.7 to 0.9 gestation, the resting wall tension increased accompanied by non-receptor-dependent (potassium) and receptor-dependent (noradrenaline; endothelin-1) increases in vasocontraction. Angiotensin II had no contractile effect at both ages. Endothelium-dependent relaxation to acetylcholine and prostaglandin E2 was absent at 0.7 but present at 0.9 gestation. Augmented vascular responsiveness was paralleled by the maturation of sympathetic and sensory vascular innervation. Non-endothelium-dependent relaxation to nitric oxide showed no maturational changes. The expression of vasoregulator receptors/enzymes did not increase between 0.7 and 0.9 gestation. Conclusion: Vascular maturation during late ovine gestation involves an increase in resting wall tension and the vasoconstrictor and vasodilator capacity of the mesenteric resistance arteries. Absence of structural changes in the tunica media and the lack of an increase in vasoregulator receptor/enzyme expression suggest that vasoactive responses are due to the maturation of intracellular pathways at this gestational age.

Keywords:
Sheep, Fetus, Vascular development
1.
Unno N, Wong CH, Jenkins SL, Wentworth RA, Ding XY, Li C, Robertson SS, Smotherman WP, Nathanielsz PW: Blood pressure and heart rate in the ovine fetus: ontogenic changes and effects of fetal adrenalectomy. Am J Physiol 1999;276:H248-H256.
2.
Shinozuka N, Yen A, Nathanielsz PW: Increased myometrial contracture frequency at 96-140 days accelerates fetal cardiovascular maturation. Am J Physiol Heart Circ Physiol 2000;278:H41-H49.
3.
Docherty CC, Kalmar-Nagy J, Engelen M, Nathanielsz PW: Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 2001;280:R554-R562.
4.
Pearce WJ, Hull AD, Long DM, Longo LD: Developmental changes in ovine cerebral artery composition and reactivity. Am J Physiol 1991;261:R458-R465.
5.
Su C, Bevan JA, Assali NS, Brinkman CR 3rd: Regional variation of lamb blood vessel responsiveness to vasoactive agents during fetal development. Circ Res 1977;41:844-848.
6.
Hanson MA: The control of heart rate and blood pressure in the fetus: theoretical considerations; in Hanson MAS, John AD, Rodeck CH (eds): Fetus and Neonate Physiology and Clinical Applications. London, Cambridge University Press, 1993, vol 1, pp 1-19.
7.
Barry JS, Anthony RV: The pregnant sheep as a model for human pregnancy. Theriogenology 2008;69:55-67.
8.
Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
9.
Anwar MA, Schwab M, Poston L, Nathanielsz PW: Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus. Am J Physiol Heart Circ Physiol 1999;276:H1137-H1143.
10.
Chern J, Kamm KE, Rosenfeld CR: Smooth-muscle myosin heavy-chain isoforms are developmentally-regulated in male fetal and neonatal sheep. Pediatr Res 1995;38:697-703.
11.
Hart MN, Heistad DD, Brody MJ: Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 1980;2:419-423.
12.
Schiffrin EL, Hayoz D: How to assess vascular remodelling in small and medium-sized muscular arteries in humans. J Hypertens 1997;15:571-584.
13.
Matuszek MA, Gibson KJ, Lumbers ER, Simonetta G: Impact of cortisol on alpha-actin content in vascular smooth muscle cells of fetal sheep. Clin Exp Pharmacol P 2006;33:197-203.
14.
Bevan JA, Bevan RD: Developmental influences on vascular structure and function. Ciba Found Symp 1981;83:94-107.
15.
Frasch MG, Muller T, Wicher C, Weiss C, Lohle M, Schwab K, Schubert H, Nathanielsz PW, Witte OW, Schwab M: Fetal body weight and the development of the control of the cardiovascular system in fetal sheep. J Physiol 2007;579:893-907.
16.
Hutanu C, Cox BE, DeSpain K, Liu XT, Rosenfeld CR: Vascular development in early ovine gestation: carotid smooth muscle function, phenotype, and biochemical markers. Am J Physiol Regul Integr Comp Physiol 2007;293:R323-R333.
17.
Coumans ABC, Garnier Y, Supcun S, Jensen A, Hasaart THM, Berger R: The role of nitric oxide on fetal cardiovascular control during normoxia and acute hypoxia in 0.75 gestation sheep. J Soc Gynecol Invest 2003;10:275-282.
18.
Arens WHJM, Rosenfeld CR, Kamm KE: Maturational differences between vascular and bladder smooth muscle during ovine development. Am J Physiol Regul Integr Comp Physiol 2000;278:R1305-R1313.
19.
Goyal R, Henderson DA, Chu N, Longo LD: Ovine middle cerebral artery characterization and quantification of ultrastructure and other features: changes with development. Am J Physiol Regul Integr Comp Physiol 2012;302:R433-R445.
20.
Blood AB, Zhao Y, Long W, Zhang L, Longo LD: L-type Ca2+ channels in fetal and adult ovine cerebral arteries. Am J Physiol Regul Integr Comp Physiol 2002;282:R131-R138.
21.
Goyal R, Creel KD, Chavis E, Smith GD, Longo LD, Wilson SM: Maturation of intracellular calcium homeostasis in sheep pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2008;295:L905-L914.
22.
Goyal R, Mittal A, Chu N, Shi L, Zhang L, Longo LD: Maturation and the role of PKC-mediated contractility in ovine cerebral arteries. Am J Physiol Heart Circ Physiol 2009;297:H2242-H2252.
23.
Long W, Zhang L, Longo LD: Cerebral artery sarcoplasmic reticulum Ca(2+) stores and contractility: changes with development. Am J Physiol Regul Integr Comp Physiol 2000;279:R860-R873.
24.
Nakanishi T, Gu H, Abe K, Momma K: Developmental changes in the contractile system of the mesenteric small artery of rabbit. Pediatr Res 1997;41:65-71.
25.
Nuwayhid B, Brinkman CR 3rd, Su C, Bevan JA, Assali NS: Development of autonomic control of fetal circulation. Am J Physiol 1975;228:337-344.
26.
Riley SC, Butt AR, Doughton BW, Li SX, Zheng SH, Findlay JK, Salamonsen LA: Endothelin in the ovine uterus during the oestrous cycle and early pregnancy. J Reprod Fertil 1994;100:451-459.
27.
Cheung CY: Adrenal growth and ontogeny of adrenal substance P, enkephalins and catecholamines in the ovine fetus. J Dev Physiol 1989;12:77-84.
28.
Cheung CY: Regulation of atrial-natriuretic-factor release by endothelin in ovine fetuses. Am J Physiol 1994;267:R380-R386.
29.
Malamitsi-Puchner A, Antsaklis A, Economou E, Mesogitis S, Papantoniou N, Koutra N, Aravantinos D: Endothelin 1-21 plasma levels in fetuses at 18-24 weeks of gestation. J Perinat Med 1995;23:321-325.
30.
Nakamura T, Kasai K, Konuma S, Emoto T, Banba N, Ishikawa M, Shimoda S: Immunoreactive endothelin concentrations in maternal and fetal blood. Life Sci 1990;46:1045-1050.
31.
Nisell H, Hemsen A, Lunell NO, Wolff K, Lundberg MJ: Maternal and fetal levels of a novel polypeptide, endothelin: evidence for release during pregnancy and delivery. Gynecol Obstet Invest 1990;30:129-132.
32.
Greenberg SG, Baker RS, Yang D, Clark KE: Effects of continuous infusion of endothelin-1 in pregnant sheep. Hypertension 1997;30:1585-1590.
33.
Jones OW 3rd, Abman SH: Systemic and pulmonary hemodynamic effects of big endothelin-1 and phosphoramidon in the ovine fetus. Am J Physiol 1994;266:R929-R955.
34.
Jones CT, Ritchie JW: The cardiovascular effects of circulating catecholamines in fetal sheep. J Physiol 1978;285:381-393.
35.
Cox BE, Rosenfeld CR: Ontogeny of vascular angiotensin II receptor subtype expression in ovine development. Pediatr Res 1999;45:414-424.
36.
Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-854.
37.
Okawa T, Honda S, Sanpei M, Ishida T, Fujimori K, Sato A: Effects of nitric oxide and prostacyclin on hemodynamic response by big endothelin-1 in near term fetal sheep. J Perinat Med 2004;32:495-499.
38.
Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF: Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203-1208.
39.
Kiowski W, Luscher TF, Linder L, Buhler FR: Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991;83:469-475.
40.
Neylon CB: Vascular biology of endothelin signal transduction. Clin Exp Pharmacol Physiol 1999;26:149-153.
41.
Thoenen H: Induction of tyrosine hydroxylase in peripheral and central adrenergic neurones by cold-exposure of rats. Nature 1970;228:861-862.
42.
Minneman KP, Pittman RN, Molinoff PB: Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci 1981;4:419-461.
43.
Longo LD, Ueno N, Zhao Y, Pearce WJ, Zhang L: Developmental changes in alpha 1-adrenergic receptors, IP3 responses, and NE-induced contraction in cerebral arteries. Am J Physiol 1996;271:H2313-H2319.
44.
McGrath JC: Localization of α-adrenoceptors: JR Vane Medal Lecture. Br J Pharmacol 2015;172:1179-1194.
45.
Lee J, Banu SK, Nithy TK, Stanley JA, Arosh JA: Early pregnancy induced expression of prostaglandin E2 receptors EP2 and EP4 in the ovine endometrium and regulated by interferon tau through multiple cell signaling pathways. Mol Cell Endocrinol 2012;348:211-223.
46.
Zhang L: Muscarinic receptors in developing rat colon. Eur J Pharmacol 1996;304:211-219.
47.
Hristovska AM, Rasmussen LE, Hansen PB, Nielsen SS, Nusing RM, Narumiya S, Vanhoutte P, Skott O, Jensen BL: Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 2007;50:525-530.
48.
Spence VA, Khan F, Kennedy G, Abbot NC, Belch JJ: Acetylcholine-mediated vasodilatation in the microcirculation of patients with chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids 2004;70:403-407.
49.
Simmons DL, Botting RM, Hla T: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004;56:387-437.
50.
Nishina H, Green LR, McGarrigle HH, Noakes DE, Poston L, Hanson MA: Effect of nutritional restriction in early pregnancy on isolated femoral artery function in mid-gestation fetal sheep. J Physiol 2003;553:637-647.
51.
Wieczorek KM, Brewer AS, Myatt L: Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol 1995;173:708-713.
52.
Li Y, Zheng J, Bird IM, Magness RR: Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells. Biol Reprod 2003;69:1053-1059.
53.
Learmont JG, Poston L: Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol 1996;174:583-588.
54.
Paul BD, Snyder SH: H2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 2012;13:499-507.
55.
Mathewson AM, Dunn WR: A comparison of responses to raised extracellular potassium and endothelium-derived hyperpolarizing factor (EDHF) in rat pressurised mesenteric arteries. PLoS One 2014;9:e111977.
56.
Molnar J, Nijland MJM, Howe DC, Nathanielsz PW: Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am J Physiol Regul Integr Comp Physiol 2002;283:R561-R567.
57.
Török J, Gerová M: Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta. Mech Ageing Dev 1997;95:143-152.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.